Science

The randomized placebo-controlled study investigating the effects of Akay Bioactives' Immufen ingredient on mild allergic rhinitis.

The five-year study will be supported by a $2.2 million grant from the National Institute of Drug Abuse.

How we can better support preparation and recovery in a population of new (older) moms.

A look at the science demonstrating the gut microbiome’s impact on bone health.

From hot flashes to mood swings, menopause is rough on women, and they are actively seeking out solutions.

Researchers used standardized questionnaires and an Oura ring to measure sleep quality and functioning after waking up.

Both a higher and lower dose of the extract was shown to reduce appetite and cravings.

Webinar Date/Time: Wed, Oct 9, 2024 8:00 AM PDT (11:00 AM EDT)

Biofortis Research has announced that it will be participating in SupplySide West 2024, taking place in Las Vegas, NV on October 30 and 31st.

NXT USA has announced the publication of a narrative review that offers an in-depth analysis of the efficacy and safety of its Digexin ingredient, which is a novel blend of Ashwagandha and okra extracts.

Understanding leaky gut syndrome and what products on the market may offer risk reduction.

The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.

A recent study found that a blend of standardized botanical extracts, called Zeropollution, may support scalp health under environmental stress.

Results showed that supplementation with the Mangifera indica extract significantly improved mental speed, attention, working memory, response inhibition, as well as verbal learning and memory.

The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.

A recent study demonstrated the potential effects of Vitamin E, in the form of tocotrienols, on memory formation and other cognitive functions.

Results showed that both doses of krill oil significantly reduced TEWL, and increased hydration as well as elasticity compared to placebo.

Helaina has launched an ingredient called effera, which it claims is the first human lactoferrin equivalent manufactured using precision fermentation.

A recently published study, originally covered by our sister brand Cannabis Science and Tecnology, demonstrated the neuroprotective properties of the supplement N-Acetylcysteine against the effects of cannabis exposure in adolescence.

Sirio Pharma has announced that its Ubidecarenone Chewable Gels have been added to the United States Pharmacopoeia (USP) monograph.

A recent published study investigated the impacts of pentadecanoic acid (C15:0) on obese participants.

Seraphina Therapeutics has announced a partnership with Genova Diagnostics to introduce the Fatty15 C15:0 Test.

A study comparing lion’s mane mushroom and guayusa extracts tested cognition, mood, and happiness in participants.

Study shows the safety and tolerability of the beetroot extract Sabeet. Researchers also observed a trend for elevated nitrate level and reduced insulin levels.

Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.

A recently published study found that Ahiflower oil from the seeds of Buglossoides arvensis may improve plasma eicosapentaenoic acid (EPA) levels.

A recently published study found that a novel keratin-based formulation called Keragen-IV from AIDP Inc. was able to support the skin and hair health in women.

A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.

In the study, the probiotic was used as an adjunct to standard treatment, and was found to support recovery.

The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.